Keywords
Diabetes Mellitus
Hypoglycemia
Chronic Renal Insufficiency
Risk Factors
Insulin
How to Cite
Abstract
The authors conclude that in patients with DM2, more advanced CKD was associated with greater insulin use, proposing different explanations of this relationship, however, we consider that in addition to these findings, within the study there are no patients using Dipeptidyl Peptidase-4 Inhibitors (DPP4i), probably by that time they were not being used yet. Therefore, patients with advanced CKD only had insulin as the only option, which explains a greater frequency of its use in this group of patients.
References
Grube D, Wei G, Boucher R, Abraham N, Zhou N, Gonce V, et al.. Insuline use in chronic kidney disease and the risk of hipoglycemic events. BMC Nephrol. 2022:23(1):73. https://doi.org/10.1186/s12882-022-02687-w
Daza-Arnedo R, Rico-Fontalvo J, Pajaro-Galvis N, Leal-Martinez V, Abuabara-Franco E, Raad-Sarabia M, et al. Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review. Kidney Med. 2021:3(6):1065-1073. https://doi.org/10.1016/j.xkme.2021.07.007
Lopera-Vargas JM, Rico-Fontalvo JE, Melgarejo E, Castillo-Barrios GA, Ramírez-Rincón A, Gómez AM, et al. Efecto de terapias farmacológicas para el control glicémico en pacientes con diabetes mellitus tipo 2 en los desenlaces vasculares. Rev Colomb Nefrol. 2020;7(1):44-59. https://doi.org/10.22265/acnef.7.1.372
Yun JS, Ko SH, Ko SH, Song KH, Ahn YB, Yoon KH, et al. Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care. 2013;36(5):1283-1289. https://doi.org/10.2337/dc12-1408
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.